China Shineway Pharmaceutical Group Limited
CSWYY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $228 | $236 | – | $2,118 |
| % Growth | -3.3% | – | – | – |
| Cost of Goods Sold | $63 | $60 | – | $528 |
| Gross Profit | $165 | $175 | – | $1,590 |
| % Margin | 72.2% | 74.5% | – | 75.1% |
| R&D Expenses | $7 | $8 | – | $62 |
| G&A Expenses | $0 | $0 | – | $188 |
| SG&A Expenses | $106 | $129 | – | $1,144 |
| Sales & Mktg Exp. | $0 | $0 | – | $956 |
| Other Operating Expenses | $0 | $0 | – | $0 |
| Operating Expenses | $113 | $137 | – | $1,068 |
| Operating Income | $51 | $38 | – | $384 |
| % Margin | 22.4% | 16.3% | – | 18.1% |
| Other Income/Exp. Net | $56 | $1 | – | $185 |
| Pre-Tax Income | $107 | $40 | – | $569 |
| Tax Expense | $22 | $10 | – | $91 |
| Net Income | $85 | $30 | – | $478 |
| % Margin | 37.2% | 12.6% | – | 22.6% |
| EPS | 44.8 | 15.8 | – | 252 |
| % Growth | 183.5% | – | – | – |
| EPS Diluted | 44.8 | 15.8 | – | 253.2 |
| Weighted Avg Shares Out | 2 | 2 | – | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | – | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17 | $8 | – | $46 |
| Interest Expense | $1 | $0 | – | $0 |
| Depreciation & Amortization | $10 | $10 | – | $80 |
| EBITDA | $118 | $50 | – | $464 |
| % Margin | 51.7% | 21.3% | – | 21.9% |